Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts

Cancer Gene Therapy

Volumn 4, Issue 2, 1997, Pages 129-138

  Nielsen, Loretta L ^a   Dell, Janet ^a   Maxwell, Eugene ^a   Armstrong, Lydia ^a   Maneval, Daniel ^a   Catino, Joseph J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Human breast cancer; Mammary cancer; Nude mice; p53 adenovirus; p53 gene therapy; p53 tumor suppressor gene

Indexed keywords

INTEGRIN;

ADENOVIRUS; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DOSE RESPONSE; EXPERIMENTAL NEOPLASM; FEMALE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; INTEGRINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031084922     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ozbun MA, Butel JS. Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res. 1995;66:71-141.
2. Marchetti A, Buttitta R, Pellegrini S, et al. p53 mutations and histological type of invasive breast carcinoma. Cancer Res. 1993;53:4665-4669.
3. Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS. Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA. 1996;93:1093-1096.
4. Saitoh S, Cunningham J, DeVries EM, et al. p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis. Oncogene. 1994;9:2869-2875.
5. Thorlacius S, Börrsen A-L, Eyfjörd JE. Somatic p53 mutations in human breast carcinomas in an icelandic population: a prognostic factor. Cancer Res. 1993;53:1637-1641.
6. Selter H, Montenarh M. The emerging picture of p53. Int J Biochem. 1994;26:145-154.
7. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
8. Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene. 1991;6:1791-1797.
9. Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res. 1994;54:1818-1824.
10. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt M-T, Huang W-M, Johnson DE, Anderson SC, Wen SF, Bookstein R, Shepard HM, Gregory RJ. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther. 1994;5:1079-1088.
11. Bartek J, Iggo R, Gannon J, et al. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. 1990;5:893-899.
12. Lesoon-Wood LA, Kim WH, Kleinman HK, et al. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther. 1995;6:395-405.
13. Harris MP, Sutjipto S, Wills KN, et al. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther. 1996;3:121-130.
14. Katayose D, Gudas J, Nguyen H, et al. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin Cancer Res. 1995;1:889-897.
15. Huyghe BG, Liu X, Sutjipto S, et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum Gene Ther. 1995;6:1403-1416.
16. Luna, LG. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. New York: McGraw Hill Book Co; 1968.
17. 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
18. 5 selectively promotes adenovirus-mediated cell membrane permeabilization following internalization. J Cell Biol. 1994;127:257-264.
19. v integrins for infection. J Virol. 1994; 68:6811-6814.
20. v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem. 1990;265:5938-5941.
21. Wilson C, Kay MA. Immunomodulation to enhance gene therapy. Nature Med. 1995;4:887-889.
22. Boven E, Winograd, B. The Nude Mouse in Oncology Research. Boston: CRC Press; 1991.
23. Hamada K, Alemany R, Zhang W-W, et al. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer. Cancer Res. 1996;56:3047-3054.
24. Eastham JA, Hall SJ, Sehgal I, et al. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res. 1995;55:5151-5155.
25. Clayman GL, El-Naggar AK, Roth JA, et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
26. Zhang W-W, Fang X, Mazur W, et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1994;1:5-13.
27. Gomez-Manzano C, Feuyo J, Kyritsis AP, et al. Adenovirus-mediated transfer of thep53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996;56:694-699.
28. Köck H, Harris MP, Anderson SC, et al. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer. 1996;67:808-815.
29. Spitz FR, Nguyen D, Skibber JM, et al. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res. 1996;2:1665-1671.